We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

CRISPR Therapeutics (NasdaqGM:CRSP) reports strong commercial momentum for its gene therapy CASGEVY, with patient initiations nearly tripling year over year. The company is preparing a regulatory ...

Relapsing after quitting cocaine is not simply a matter of willpower — it reflects physical changes in the brain, according to new research. Scientists have found that repeated cocaine use reshapes ...

A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.

Artificial intelligence is helping scientists refine gene-editing tools with greater accuracy and fewer risks, marking a step forward in efforts to treat inherited diseases through targeted DNA ...

The field of plant biotechnology has quickly evolved with the advent of CRISPR-mediated gene editing, fundamentally transforming the exploration and ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 4.8% over the past month. This reflects concerns over the commercial potential of its new drugs, Journavx and Casgevy, recent pipeline ...

Christopher Sims, the John J. F. Sherrerd ’52 University Professor of Economics, Emeritus, and a Nobel laureate whose work transformed how central banks and government leaders understand the economy, ...

A tiny plant’s molecular “velcro” could help crops turn sunlight into food more efficiently. An international team of scientists has identified a surprising molecular strategy used by a rare group of ...

When bacteria cells replicate, they do so a little differently than human cells do. They don't undergo mitosis, a splitting that involves construction of spindles to carefully separate the DNA after ...